연구성과로 돌아가기

2024 연구성과별 연구자 정보 (447 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Hong, Sung-Hoo Hong, SH 7 Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Urol, Seoul, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Park, Sungchan Park, S 8 Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Urol, Ulsan, South Korea 0000-0002-2337-983X Park, Sungchan skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Lee, Seung Hwan Lee, SH 9 Yonsei Univ, Coll Med, Severance Hosp, Dept Urol, Seoul, South Korea AAE-4710-2022 Lee, Seung Hwan skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Cho, Jin Seon Cho, JS 10 Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Urol, Anyang, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Park, Sung-Woo Park, SW 11 Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Urol, Yangsan, South Korea N-9769-2016 Park, Sung-Woo skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Kwon, Se Yun Kwon, SY 12 Dongguk Univ, Coll Med, Dept Urol, Gyeongju, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Jo, Jung Ki Jo, JK 13 Hanyang Univ, Coll Med, Dept Urol, Seoul, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Park, Hong Seok Park, HS 14 Korea Univ, Coll Med, Dept Urol, Seoul, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Lee, Sang-Cheol Lee, SC 15 Chungbuk Natl Univ, Coll Med, Chungbuk Natl Univ Hosp, Dept Urol, Cheongju, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Kwon, Dong Deuk Kwon, DD 16 Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Urol, Hwasun, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Kim, Sun Il Kim, SI 17 Ajou Univ, Sch Med, Dept Urol, Suwon, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Park, Sang Hyun Park, SH 18 Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Urol, Busan, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Kim, Soodong Kim, S 19 Dong A Univ, Coll Med, Dept Urol, Busan, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Jeong, Chang Wook Jeong, CW 20 Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Urol, Seoul, South Korea skhwan.script@gmail.com;
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer Kwak, Cheol Kwak, C 21 Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Urol, Seoul, South Korea J-2731-2012 Kwak, Cheol 0000-0002-1987-2111 Kwak, Cheol skhwan.script@gmail.com;
페이지 이동: